The Pharmacy Times® Flu Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of influenza, a contagious viral infection that can cause mild to severe symptoms and life-threatening complications.
May 1st 2024
Although the CDC continues to emphasize that risk to humans is currently low, patients will have questions.
Reducing Barriers Associated With Pneumococcal Vaccine Uptake
1.5 Credits / Immunization, Infectious Diseases
View More
Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling
1.0 Credit / Infectious Diseases, Pulmonology/Respiratory
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Maximizing Patient Safety and Efficacy With Oxymetazoline OTC Products and the Management of Nasal Congestion: A Pharmacist's Guide to Optimal Use (Pharmacy Technician Credit)
2.0 Credits / OTC
View More
Maximizing Patient Safety and Efficacy With Oxymetazoline OTC Products and the Management of Nasal Congestion: A Pharmacist's Guide to Optimal Use
2.0 Credits / OTC
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape
1.25 Credits / Immunization, Infectious Disease
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Role of Daily Photoprotection and Antioxidants in Sun Protection: A Guide for Pharmacists and Pharmacy Technicians (Pharmacy Technician)
1.0 Credit / Dermatology, OTC
View More
The Role of Daily Photoprotection and Antioxidants in Sun Protection: A Guide for Pharmacists and Pharmacy Technicians
1.0 Credit / Dermatology, OTC
View More
Adjunctive Therapies in Atopic Dermatitis: Understanding the Role of the Skin Barrier and Microbiome in Disease Management
1.0 Credit / Dermatology, OTC
View More
Skin-Related Changes in Persons With Diabetes: Using Ceramides to Address Skin Barrier Dysfunction (Pharmacy Technician Credit)
1.0 Credit / Dermatology, OTC
View More
Skin-Related Changes in Persons With Diabetes: Using Ceramides to Address Skin Barrier Dysfunction
1.0 Credit / Dermatology, OTC
View More
Understanding the Role of Ceramides in Acne Management: Opportunities to Improve Clinical Outcomes
1.0 Credit / Dermatology, OTC
View More
Adjunctive Therapies in Atopic Dermatitis: Understanding the Role of the Skin Barrier and Microbiome in Disease Management (Pharmacy Technician Credit)
1.0 Credit / Dermatology, OTC
View More
Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction
0.75 Credit / Dermatology, OTC
View More
Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction (Pharmacy Technician Credit)
0.75 Credit / Dermatology, OTC
View More
Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective (Pharmacy Technici...
0.5 Credit / Dermatology, OTC
View More
Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective
0.5 Credit / Dermatology, OTC
View More
Phase 3 Study of Coadministration of Seasonal Flu Vaccine With Prevnar 20 Shows Promising Results
September 29th 2021The researchers noted the importance of maintaining vaccination rates for conditions that can lead to respiratory issues, especially with COVID-19 cases still raising concern throughout the United States.
Read More
How Pharmacists Can Help to Improve Flu Vaccination Rates in Vulnerable Populations
September 27th 2021Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), discusses the SHC’s recently released Flu DRIVE Toolkit, which was designed to help overburdened health systems improve flu vaccination rates among vulnerable populations.
Watch
Experts Outline COVID-19 Trends, Flu Season Predictions
August 31st 2021Doug Long, vice president of industry relations at IQVIA, and Scott Biggs, director of supplier services, discussed their session at the 2021 National Association of Chain Drug Stores (NACDS) Total Store Expo titled "Pharmaceutical Trends, Issues, and Forecasts."
Watch
COVID-19 Boosters, Flu Season, and the Future of the Pandemic
August 27th 2021In an interview with Pharmacy Times®, Sachin Nagrani, MD, medical director at the home visit and telemedicine service Heal, discusses the Biden administration's announcement that booster shots will soon be available for the Pfizer and Moderna vaccines, and what this would mean for patients and practitioners.
Watch
Coadministration of Flu Vaccine with Routine Immunizations
Coadministration of the flu vaccine with other immunizations traditionally offered during flu season that pharmacies should continue to encourage.
Watch
Reasons For the Mild Flu Season and Upcoming Predictions
Jennifer Adams, PharmD, EdD, leads discussion on reasons for the mild flu season this previous year and share predictions for the upcoming flu season.
Watch
Leveling Up for Flu Season in the COVID-19 Era: How One Pharmacy Is Rising to the Challenge
July 21st 2021Kevin Day, PharmD, president of Day’s Miami Heights Pharmacy in Cincinnati, Ohio, discusses how his independent pharmacy is gearing up for influenza season while continuing to deliver COVID-19 vaccines safely.
Read More
Equal but Not the Same—2021 Update on Influenza Vaccines
As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.
Read More
First Participant Dosed in Phase 1/2 Study of Moderna’s Quadrivalent Seasonal Flu mRNA Vaccine
July 13th 2021The study plans to enroll approximately 180 participants to evaluate the safety, reactogenicity, and immunogenicity of its quadrivalent seasonal influenza mRNA vaccine in adults 18 years and older.
Read More